Newron Pharmaceuticals S.p.A. carries a market capitalization of 237.28M, placing it among publicly traded companies globally.
| Market Cap | 237.28M |
| Enterprise Value | N/A |
Newron Pharmaceuticals S.p.A.'s stock has gained approximately 70.36494% over the past 52 weeks. The 50-day moving average sits at 7.53, while the 200-day moving average is 5.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | 70.36494% |
| 50-Day Moving Average | 7.53 |
| 200-Day Moving Average | 5.82 |
| Average Volume (20 Days) | N/A |